|
Market Closed -
Euronext Paris
11:55:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 13.10 EUR | -3.53% |
|
-7.22% | +148.81% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENFIT | Other Biotechnology & Medical Research | -3.53% | -7.22% | +148.81% | +280.15% | +283.71% | 790M |  |  | |
- Stock Market
- Stocks
- GNFT Stock
- Charts GENFIT
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
